01833.HK
Ping An Healthcare and Technology Company Limited
HKSE · Healthcare · Medical - Healthcare Information Services · CN
HKD 6.54
+4.39%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 10.6B | 5.5B | 4.8B | 4.7B | 6.2B |
| Cost of Revenue | 7.1B | 3.7B | 3.3B | 3.2B | 4.5B |
| Gross Profit | 3.6B | 1.8B | 1.5B | 1.5B | 1.7B |
| Operating Expenses | |||||
| R&D Expense | 325.6M | — | — | — | — |
| SG&A Expense | 3.4B | 1.7B | 1.7B | 2.3B | 2.9B |
| General & Admin Expense | 1.8B | 845.8M | 930.0M | 1.5B | 1.7B |
| Selling & Marketing Expense | 1.6B | 828.9M | 763.5M | 835.8M | 1.1B |
| Other Expenses | (371.5M) | — | (81.1M) | (232.9M) | (471.2M) |
| Total Operating Expenses | 3.4B | 1.7B | 1.6B | 2.1B | 2.4B |
| Cost and Expenses | 10.4B | 5.4B | 4.9B | 5.2B | 6.9B |
| Operating Income (EBIT) | 212.9M | 97.6M | (89.1M) | (575.3M) | (726.3M) |
| Non-Operating | |||||
| Interest Income | 345.9M | 109.2M | 186.0M | 262.1M | 269.1M |
| Interest Expense | 3.4M | 2.7M | 3.4M | 6.9M | 11.1M |
| Net Interest Income | 342.5M | 106.5M | 182.6M | 255.2M | 257.9M |
| Other Non-Op Income/Expense | 448.2M | 283.2M | 182.8M | 243.4M | 90.2M |
| Non-Operating Income (excl Interest) | (334.0M) | (113.5M) | (186.2M) | (250.3M) | 395.9M |
| EBT (Pre-Tax Income) | 661.1M | 380.8M | 93.8M | (331.9M) | (636.2M) |
| Income Tax Expense | 38.7M | 2.8M | 5.5M | 3.0M | 3.4M |
| Bottom Line | |||||
| Net Income | 620.6M | 379.5M | 81.4M | (322.6M) | (636.1M) |
| Earnings from Cont. Ops | 622.4M | 378.0M | 88.3M | (334.9M) | (639.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 620.6M | 379.5M | 81.4M | (322.6M) | (636.1M) |
| Per Share | |||||
| Basic EPS | HK$0.31 | HK$0.18 | HK$0.08 | (HK$0.30) | (HK$0.59) |
| Diluted EPS | HK$0.31 | HK$0.18 | HK$0.08 | (HK$0.30) | (HK$0.59) |
| Revenue Per Share | HK$5.00 | HK$2.65 | HK$4.44 | HK$4.33 | HK$5.74 |
| Shares | |||||
| Basic Shares Outstanding | 2.1B | 2.1B | 1.1B | 1.1B | 1.1B |
| Diluted Shares Outstanding | 2.1B | 2.1B | 1.1B | 1.1B | 1.1B |
| Profitability Metrics | |||||
| EBITDA | 687.4M | 238.7M | 193.4M | (164.2M) | (1.0B) |
| D&A | 140.5M | 27.6M | 96.3M | 160.8M | 73.5M |
| EBIT | 546.9M | 211.1M | 97.2M | (325.0M) | (1.1B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026